{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:59:14Z","timestamp":1785826754435,"version":"3.56.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"National Institute of Health","award":["U10EY022879, U10EY022881, R21EY031338, R01EY026972"],"award-info":[{"award-number":["U10EY022879, U10EY022881, R21EY031338, R01EY026972"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate intereye agreement in dry-eye disease (DED) signs in the Dry Eye Assessment and Management study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Tear break-up time (TBUT), Schirmer test, conjunctival staining, corneal staining, meibomian gland dysfunction (MGD), and tear osmolarity were measured at baseline, 3, 6, and 12 months. Intereye agreement was assessed by intraclass correlation coefficient, weighted kappa, and percentage of participants with absolute intereye difference (AID) exceeding a clinically significant threshold (2 points for conjunctival staining and MGD, 2 seconds for TBUT, 3 points for corneal staining, 5 mm\/5 minutes for Schirmer test, and 8 mOsms\/L for osmolarity). The worse eye at each visit for each DED sign was determined as the eye with a sign worse than the contralateral eye by at least the clinically significant threshold.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>DED signs had moderate-to-good intereye agreement with intraclass correlation coefficient ranging from 0.45 (tear osmolarity) to 0.81 (corneal staining and Schirmer test) and weighted kappa from 0.58 (plugging) to 0.69 (lid secretion). Percentage of participants exceeding threshold AID was 15% to 20% for conjunctival staining, 11% to 15% for TBUT, 17% to 21% for MGD, 13% to 18% for corneal staining, 21% to 23% for Schirmer test, and 44% to 47% for osmolarity. The eye with a worse DED sign ranged between 36% (TBUT) and 80% (osmolarity) of participants.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Participants demonstrated moderate-to-good intereye agreement, yet a substantial portion showed clinically significant intereye differences in each sign. The worse eye was not the same eye in the majority during follow-up. These findings suggest considering signs from both eyes in future DED trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003605","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T02:00:32Z","timestamp":1722391232000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intereye Agreement in Dry-Eye Signs in the DREAM Study: Implications for Future Dry-Eye Trials"],"prefix":"10.1097","volume":"44","author":[{"given":"Anny","family":"Zhong","sequence":"first","affiliation":[{"name":"Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"},{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augello","sequence":"additional","affiliation":[{"name":"Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Asbell","sequence":"additional","affiliation":[{"name":"University of Memphis, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-1355","authenticated-orcid":false,"given":"Gui-Shuang","family":"Ying","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"},{"name":"Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA;"},{"name":"Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the DREAM Study Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"R1-20250109","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf."},{"key":"R2-20250109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaophthalmol.2014.3600","article-title":"Randomizing 1 eye or 2 eyes: a missed opportunity","volume":"133","author":"Glassman","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"R3-20250109","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol."},{"key":"R4-20250109","doi-asserted-by":"crossref","first-page":"7542929","DOI":"10.1155\/2016\/7542929","article-title":"Review: the lacrimal gland and its role in dry eye","volume":"2016","author":"Conrady","year":"2016","journal-title":"J Ophthalmol."},{"key":"R5-20250109","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ophtha.2018.01.025","article-title":"Influence of meibomian gland dysfunction and friction-related disease on the severity of dry eye","volume":"125","author":"Vu","year":"2018","journal-title":"Ophthalmology"},{"key":"R6-20250109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajo.2019.02.024","article-title":"Meibomian gland dysfunction and dry eye are similar but different based on a population-based study: the Hirado-Takushima Study in Japan","volume":"207","author":"Arita","year":"2019","journal-title":"Am J Ophthalmol."},{"key":"R7-20250109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archopht.1973.01000040003001","article-title":"Shall we count numbers of eyes or numbers of subjects?","volume":"89","author":"Ederer","year":"1973","journal-title":"Arch Ophthalmol."},{"key":"R8-20250109","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","article-title":"Rethinking dry eye disease: a perspective on clinical implications","volume":"12","author":"Bron","year":"2014","journal-title":"Ocul Surf."},{"key":"R9-20250109","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","article-title":"TFOS DEWS II clinical trial design report","volume":"15","author":"Novack","year":"2017","journal-title":"Ocul Surf."},{"key":"R10-20250109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cct.2018.06.002","article-title":"Dry eye Assessment and management (DREAM\u00a9) study: study design and baseline characteristics","volume":"71","author":"Asbell","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"R11-20250109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtos.2019.08.002","article-title":"The Dry Eye Assessment and Management (DREAM) extension study - a randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease","volume":"18","author":"Hussain","year":"2020","journal-title":"Ocul Surf."},{"key":"R12-20250109","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"R13-20250109","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajo.2023.03.008","article-title":"NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE Study","volume":"252","author":"Sheppard","year":"2023","journal-title":"Am J Ophthalmol."},{"key":"R14-20250109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2021.12.007","article-title":"A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: the MYSTIC study","volume":"24","author":"Quiroz-Mercado","year":"2022","journal-title":"Ocul Surf."},{"key":"R15-20250109","first-page":"1","article-title":"Capability of the inter-eye differences in osmolarity, break-up time and corneal staining on the diagnostic of dry eye","author":"Pena-Verdeal","year":"2023","journal-title":"Ocul Immunol Inflamm."},{"key":"R16-20250109","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","article-title":"Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management","volume":"31","author":"Sullivan","year":"2012","journal-title":"Cornea."},{"key":"R17-20250109","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1167\/iovs.10-5390","article-title":"An objective approach to dry eye disease severity","volume":"51","author":"Sullivan","year":"2010","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"R18-20250109","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajo.2010.10.032","article-title":"Tear osmolarity in the diagnosis and management of dry eye disease","volume":"151","author":"Lemp","year":"2011","journal-title":"Am J Ophthalmol."},{"key":"R19-20250109","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","article-title":"Predictors of discordance between symptoms and signs in dry eye disease","volume":"124","author":"Vehof","year":"2017","journal-title":"Ophthalmology"},{"key":"R20-20250109","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjophthalmol-2017-310633","article-title":"Epidemiology of discordance between symptoms and signs of dry eye","volume":"102","author":"Ong","year":"2018","journal-title":"Br J Ophthalmol."},{"key":"R21-20250109","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/09286586.2023.2248629","article-title":"Association of dry eye symptoms and signs in patients with dry eye disease","volume":"31","author":"Tawfik","year":"2023","journal-title":"Ophthalmic Epidemiol."},{"key":"R22-20250109","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ajo.2011.08.032","article-title":"Choice of analytic approach for eye-specific outcomes: one eye or two?","volume":"153","author":"Karakosta","year":"2012","journal-title":"Am J Ophthalmol."},{"key":"R23-20250109","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.82.8.971","article-title":"People and eyes: statistical approaches in ophthalmology","volume":"82","author":"Murdoch","year":"1998","journal-title":"Br J Ophthalmol."},{"key":"R24-20250109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09286586.2017.1320413","article-title":"Tutorial on biostatistics: statistical analysis for correlated binary eye data","volume":"25","author":"Ying","year":"2018","journal-title":"Ophthalmic Epidemiol."},{"key":"R25-20250109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09286586.2020.1786590","article-title":"Tutorial on biostatistics: longitudinal analysis of correlated continuous eye data","volume":"28","author":"Ying","year":"2021","journal-title":"Ophthalmic Epidemiol."}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T22:03:52Z","timestamp":1736460232000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003605","relation":{},"ISSN":["0277-3740","1536-4798"],"issn-type":[{"value":"0277-3740","type":"print"},{"value":"1536-4798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"2024-01-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}